35 patents
Page 2 of 2
Utility
Deuterated Analogs of D-serine and Uses Thereof
25 Nov 20
This disclosure relates to deuterated D-serine, pharmaceutically acceptable salts thereof, analogs and prodrugs thereof, pharmaceutical compositions thereof, and methods of use.
Dario Doller, Christopher L. Brummel, Julie F. Liu, Roger D. Tung
Filed: 20 Nov 18
Utility
Deuterated idebenone
23 Nov 20
Roger D. Tung
Filed: 15 May 19
Utility
Deuterated baricitinib
23 Nov 20
Roger D. Tung
Filed: 29 Mar 18
Utility
Morphinan compounds
26 Oct 20
This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof.
Philip B. Graham, I. Robert Silverman
Filed: 25 Jul 19
Utility
Treatment of Hair Loss Disorders with Deuterated Jak Inhibitors
15 Jul 20
Amanda T. Wagner, James V. Cassella, Philip B. Graham, Virginia Braman, Vinita Uttamsingh, Jana Von Hehn, Colleen E. Hamilton
Filed: 4 Dec 19
Utility
Deuterated OTX-015
15 Jun 20
This invention relates to novel thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepines, and pharmaceutically acceptable salts thereof.
Scott L. Harbeson, Julie F. Liu
Filed: 26 Apr 16
Utility
Deuterated analogs of D-serine and uses thereof
1 Jun 20
This disclosure relates to deuterated D-serine, pharmaceutically acceptable salts thereof, analogs and prodrugs thereof, pharmaceutical compositions thereof, and methods of use.
Dario Doller, Christopher L. Brummel, Julie F. Liu, Roger D. Tung
Filed: 1 Jul 19
Utility
Treatment of hair loss disorders with deuterated JAK inhibitors
17 Feb 20
Amanda T. Wagner, James V. Cassella, Philip B. Graham, Virginia Braman, Vinita Uttamsingh, Jana Von Hehn, Colleen E. Hamilton
Filed: 3 May 17
Utility
Morphinan Compounds
22 Jan 20
This invention relates to novel morphinan compounds and pharmaceutically acceptable salts thereof.
Philip B. Graham, I. Robert Silverman
Filed: 25 Jul 19
Utility
4-hydroxybutyric acid analogs
13 Jan 20
This invention relates to novel derivatives of 4-hydroxybutyric acid and prodrugs thereof, and pharmaceutically acceptable salts of the foregoing.
Roger D. Tung
Filed: 12 Nov 17
Utility
Deuterated Idebenone
4 Dec 19
Roger D. Tung
Filed: 15 May 19
Utility
Deuterated Morphinan Compounds for Treating Agitation
6 Nov 19
This invention relates to methods of treating agitation comprising administering a morphinan compound or a pharmaceutically acceptable salt thereof.
Roger D. Tung, Philip B. Graham
Filed: 21 Jul 19
Utility
Deuterated Analogs of D-serine and Uses Thereof
30 Oct 19
This disclosure relates to deuterated D-serine, pharmaceutically acceptable salts thereof, analogs and prodrugs thereof, pharmaceutical compositions thereof, and methods of use.
Dario Doller, Christopher L. Brummel, Julie F. Liu, Roger D. Tung
Filed: 1 Jul 19
Utility
Deuterated GFT-505
14 Oct 19
This invention relates to novel deuterated forms of GFT-505, and pharmaceutically acceptable salts thereof.
Roger D. Tung
Filed: 15 Feb 17
Utility
Deuterated Derivatives of Ruxolitinib
9 Oct 19
I. Robert Silverman, Julie F. Liu, Adam J. Morgan, Bhaumik Pandya, Scott L. Harbeson
Filed: 10 Mar 19